Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Pazopanib Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

48 API Suppliers, 14 USDMF, 1 JDMF, 9 EU WC, 5 KDMF, 9 NDC API, 34 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

96 Drugs in Development

96 Drugs in Development

INTERMEDIATES

45 Intermediate Suppliers

45 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

82 FDF Dossiers, 8 FDA Orange Book, 36 Europe, 3 Canada, 12 Australia, 5 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 200MG BASE, TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 5 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 1 ACG Worldwide, 2 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 10 BASF, 1 Clariant, 10 Corel Pharma Chem, 3 DFE Pharma, 9 Gangwal Chemicals, 4 Ideal Cures, 1 Ingredion Pharma Solutions, 10 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 12 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives, 30 Fillers, Diluents & Binders, 17 Solubilizers, 17 Controlled & Modified Release, 16 Thickeners and Stabilizers, 15 Disintegrants & Superdisintegrants, 13 Granulation, 13 Direct Compression, 10 Lubricants & Glidants, 10 Film Formers & Plasticizers, 9 Parenteral, 8 Co-Processed Excipients, 6 Rheology Modifiers, 5 Empty Capsules, 5 Coloring Agents, 5 Emulsifying Agents, 5 Topical, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 API Stability Enhancers, 4 Taste Masking, 4 Chewable & Orodispersible Aids

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 15 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 10 Annual Reports

MARKET PLACE

3 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 USP

3 USP

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
21/11/2025	Shandong Loncom Pharmaceutical	China	Shandong Loncom Pharmaceutical Co., Ltd.	SD240001	Pazopanib Hydrochloride	2023-10-23	2027-01-08	127, Qizhong Avenue, Yanbei Sub-district, Qihe County, Dezhou City, Shandong Province, 251
04/06/2025	BDR Lifesciences	India	M/s BDR lifesciences Pvt Ltd	WC-0340	Pazopanib Hydrochloride IH	2022-09-30	2025-04-14	R.S No: 578, Near Effluent Channel, at & Post: Luna, Taluka: Padra, District: Vadodara-391440, India

Pazopanib Hydrochloride

Pazopanib Hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

48 API Suppliers

14 USDMF

1 JDMF

9 EU WC

5 KDMF

9 NDC API

34 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

96 Drugs in Development

INTERMEDIATES

45 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

82 FDF Dossiers

8 FDA Orange Book

36 Europe

3 Canada

12 Australia

5 South Africa

18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 200MG BASE

TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

5 DKSH

1 Boai NKY Pharmaceuticals Ltd

3 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Kirsch Pharma

1 ACG Worldwide

2 Actylis

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

10 BASF

1 Clariant

10 Corel Pharma Chem

3 DFE Pharma

9 Gangwal Chemicals

4 Ideal Cures

1 Ingredion Pharma Solutions

10 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

9 Microlex e.U

1 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Novo Excipients

3 Pharmatrans-Sanaq

2 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

11 Roquette

12 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

3 Silverline Chemicals

2 The Dow Chemical Company

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives

30 Fillers, Diluents & Binders

17 Solubilizers

17 Controlled & Modified Release

16 Thickeners and Stabilizers

15 Disintegrants & Superdisintegrants

13 Granulation

13 Direct Compression

10 Lubricants & Glidants

10 Film Formers & Plasticizers

9 Parenteral

TABLET;ORAL - EQ 400MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons